Interchange Capital Partners’s Boston Scientific BSX Stock Holding History

Interchange Capital Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$215K	Sell	2,319 -3,168	-58%	-$253K	0.07%	253
2025 Q4	$523K	Buy	5,487 +1,122	+26%	+$110K	0.1%	188
2025 Q3	$426K	Buy	4,365 +1,790	+70%	+$185K	0.08%	207
2025 Q2	$277K	Buy	2,575 +278	+12%	+$28.1K	0.06%	235
2025 Q1	$232K	Buy	+2,297	New	+$231K	0.06%	243
2021 Q1	–	Sell	-287	Closed	-$10K	–	343
2020 Q4	$10K	Buy	+287	New	+$10.3K	0.01%	782

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Interchange Capital Partners's BSX Position: Q1 2026 in Review

Interchange Capital Partners reduced its Boston Scientific (BSX) stake by 58% in Q1 2026, selling an estimated $253K and leaving 2,319 shares worth $215K. The position accounts for 0.07% of the portfolio, ranked #253.

Interchange Capital Partners first reported a position in BSX in Q4 2020 and has held it in 6 quarters since. The position peaked at $523K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Interchange Capital Partners held 2,319 shares of Boston Scientific worth $215K as of Q1 2026.
Interchange Capital Partners sold 3,168 Boston Scientific shares in Q1 2026, an estimated $253K.
Boston Scientific made up 0.07% of Interchange Capital Partners's portfolio in Q1 2026, its #253 holding.
Interchange Capital Partners first reported a position in Boston Scientific in Q4 2020 and has held it in 6 quarters since.
Interchange Capital Partners's Boston Scientific position peaked at $523K in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Interchange Capital Partners's 13F filing for Q1 2026, filed 24 Apr 2026.